ACET Adicet Bio Inc

USD 2.69 -0.16 -5.614035
Icon

Adicet Bio Inc (ACET) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.69

-0.16 (-5.61)%

USD 0.23B

2.88M

USD 8.33(+209.79%)

USD 18.88 (+601.86%)

Icon

ACET

Adicet Bio Inc (USD)
COMMON STOCK | NSD
USD 2.69
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.23B

USD 18.88 (+601.86%)

USD 2.69

Adicet Bio Inc (ACET) Stock Forecast

Show ratings and price targets of :
USD 8.33
(+209.79%)

Based on the Adicet Bio Inc stock forecast from 1 analysts, the average analyst target price for Adicet Bio Inc is USD 8.33 over the next 12 months. Adicet Bio Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Adicet Bio Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Adicet Bio Inc’s stock price was USD 2.69. Adicet Bio Inc’s stock price has changed by -7.24% over the past week, +10.25% over the past month and -65.73% over the last year.

No recent analyst target price found for Adicet Bio Inc
No recent average analyst rating found for Adicet Bio Inc

Company Overview Adicet Bio Inc

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tum...Read More

https://www.adicetbio.com

200 Clarendon Street, Boston, MA, United States, 02116

132

June

USD

USA

Adjusted Closing Price for Adicet Bio Inc (ACET)

Loading...

Unadjusted Closing Price for Adicet Bio Inc (ACET)

Loading...

Share Trading Volume for Adicet Bio Inc Shares

Loading...

Compare Performance of Adicet Bio Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ACET

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Adicet Bio Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.01 (-0.24%) USD90.49B 26.38 17.57

ETFs Containing ACET

Symbol Name ACET's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Adicet Bio Inc (ACET) Stock

Based on ratings from 1 analysts Adicet Bio Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on ACET's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for ACET is USD 8.33 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 5.

ACET stock's Price/Earning ratio is 39.60. Our analysis grades ACET stock's Price / Earning ratio at F. This means that ACET stock's Price/Earning ratio is above 82% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ACET may be a overvalued for its sector.

The last closing price of ACET's stock was USD 2.69.

The most recent market capitalization for ACET is USD 0.23B.

Based on targets from 1 analysts, the average taret price for ACET is projected at USD 8.33 over the next 12 months. This means that ACET's stock price may go up by +209.79% over the next 12 months.

We can't find any ETFs which contains Adicet Bio Inc's stock.

As per our most recent records Adicet Bio Inc has 132 Employees.

Adicet Bio Inc's registered address is 200 Clarendon Street, Boston, MA, United States, 02116. You can get more information about it from Adicet Bio Inc's website at https://www.adicetbio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...